Chemoinformaics analysis of cis-10-nonadecenoic acid
| Molecular Weight | 296.495 | nRot | 16 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 2 |
| Exact Molecular Weight | 296.272 | nRing | 0 |
| Solubility: LogS | -3.274 | nHRing | 0 |
| Solubility: LogP | 6.616 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 57.3385 |
| nHD | 1 | BPOL | 36.9835 |
| QED | 0.261 |
| Synth | 2.048 |
| Natural Product Likeliness | 0.828 |
| NR-PPAR-gamma | 0.98 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.039 |
| CACO-2 | -5.06 |
| MDCK | 0.0000338 |
| BBB | 0.017 |
| PPB | 0.994656 |
| VDSS | 0.797 |
| FU | 0.00530596 |
| CYP1A2-inh | 0.258 |
| CYP1A2-sub | 0.199 |
| CYP2c19-inh | 0.236 |
| CYP2c19-sub | 0.07 |
| CYP2c9-inh | 0.164 |
| CYP2c9-sub | 0.992 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.179 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.02 |
| CL | 2.632 |
| T12 | 0.791 |
| hERG | 0.071 |
| Ames | 0.014 |
| ROA | 0.034 |
| SkinSen | 0.945 |
| Carcinogencity | 0.083 |
| EI | 0.967 |
| Respiratory | 0.872 |
| NR-Aromatase | 0.085 |
| Antiviral | No |
| Prediction | 0.58312 |